Stock overview
Catalyst Pharmaceuticals, Inc.
Explore the company, reported ownership, price history, and available source evidence.
Historical Catalyst Pharmaceuticals common stock, traded as CPRX. Angelini Pharma acquired the company for $31.50 cash per share on July 15, 2026. Nasdaq identifies July 14 as the last trading date.
- Last close
- $31.48
- · CPRX
- Tracked holders
- 0 funds
- Latest available 13F per fund
CPRX · USD
Price
Close · Jul 14, 2026
- Range low
- $31.48
- Range high
- $31.48
- Observations
- 1
- Session date
- Jul 14, 2026
Jul 14, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Latest reported institutional positions from SEC 13F filings.
No tracked fund's latest available 13F reports CPRX.
This state describes the stored filings; it does not imply a current position.
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market